These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9918267)

  • 1. Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology.
    Wells G; Boers M; Shea B; Tugwell P; Westhovens R; Saurez-Almazor M; Buchbinder R
    J Rheumatol; 1999 Jan; 26(1):217-21. PubMed ID: 9918267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P; Idzerda L; Wells GA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P; Idzerda L; Wells GA
    Am J Manag Care; 2008 Apr; 14(4):234. PubMed ID: 18415966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.
    Kosinski M; Kujawski SC; Martin R; Wanke LA; Buatti MC; Ware JE; Perfetto EM
    Am J Manag Care; 2002 Mar; 8(3):231-40. PubMed ID: 11915973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 3 quality of life instruments in the longitudinal study of rheumatoid arthritis].
    Bouchet C; Guillemin F; Briançon S
    Rev Epidemiol Sante Publique; 1995; 43(3):250-8. PubMed ID: 7784674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
    Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis.
    Fries JF; Ramey DR
    J Rheumatol; 1997 Sep; 24(9):1697-702. PubMed ID: 9292790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.
    Salaffi F; Stancati A; Carotti M
    Clin Rheumatol; 2002 Nov; 21(6):478-87. PubMed ID: 12447631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
    Harrison MJ; Tricker KJ; Davies L; Hassell A; Dawes P; Scott DL; Knight S; Davis M; Mulherin D; Symmons DP
    J Rheumatol; 2005 Dec; 32(12):2330-6. PubMed ID: 16331758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.
    Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE
    Arthritis Rheum; 2000 Jul; 43(7):1478-87. PubMed ID: 10902749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological status is associated with health related quality of life in patients with rheumatoid arthritis.
    Nas K; Sarac AJ; Gur A; Cevik R; Altay Z; Erdal A; Ersoy Y; Kaya A; Tekeoglu I; Ugur M; Durmus B; Ardicoglu O; Senel K; Baysal O; Kamanli A; Karatay S; Yildirim K; Ozgocmen S
    J Back Musculoskelet Rehabil; 2011; 24(2):95-100. PubMed ID: 21558614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments.
    Hagen KB; Smedstad LM; Uhlig T; Kvien TK
    J Rheumatol; 1999 Jul; 26(7):1474-80. PubMed ID: 10405932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis.
    van der Heide A; Jacobs JW; Schenk Y; Bijlsma JW
    J Rheumatol; 1994 Dec; 21(12):2195-9. PubMed ID: 7699618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.